Atlas Trials

Development and Prospective Validation of a Standardized Flow Cytometric Assay of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes.

Clinical trial NCT04399018 · UNKNOWN

Trial details

NCT number
NCT04399018
Sponsor
University Hospital, Grenoble
Status
UNKNOWN
Study type
OBSERVATIONAL
Myelodysplastic Syndromes
Start date
2020-07-27
Primary completion
2024-08-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.